BiotechTube

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Presbyopia

Conditions

Presbyopia, Near Vision, Refractive Error, Eye Diseases

Trial Timeline

Mar 6, 2023 → Jan 24, 2024

NCT ID
NCT05728944

About Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle is a phase 3 stage product being developed by LENZ Therapeutics for Presbyopia. The current trial status is completed. This product is registered under clinical trial identifier NCT05728944. Target conditions include Presbyopia, Near Vision, Refractive Error.

What happened to similar drugs?

1 of 5 similar drugs in Presbyopia were approved

Approved (1) Terminated (1) Active (4)
✅AGN-190584AbbVieApproved
🔄AGN-190584 + VehicleAbbViePhase 3
🔄Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 3
🔄Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionLENZ TherapeuticsPhase 3
🔄Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidineLENZ TherapeuticsPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05728944Phase 3Completed

Competing Products

14 competing products in Presbyopia

See all competitors
ProductCompanyStageHype Score
AGN-241622 + VehicleAbbViePhase 1/2
24
AGN-190584AbbVieApproved
35
AGN-190584 + VehicleAbbViePhase 3
40
UNR844 + PlaceboNovartisPhase 2
27
UNR844-Cl + PlaceboNovartisPhase 2
35
Pilocarpine Ophthalmic Topical Cream, Dose 1 + Pilocarpine Ophthalmic Topical Cream, Dose 2 + Pilocarpine Ophthalmic Topical Cream, Dose 3 + Placebo Ophthalmic Topical CreamGlaukosPhase 2
32
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 3
30
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionLENZ TherapeuticsPhase 2
25
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionLENZ TherapeuticsPhase 3
30
PRX-100 + PlaceboLENZ TherapeuticsPhase 2
25
Aceclidine+tropicamide combination + Aceclidine + VehicleLENZ TherapeuticsPhase 2
25
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution + LNZ100 (Aceclidine) ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 1
19
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle proprietary ophthalmic solutionLENZ TherapeuticsPhase 2
25
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidineLENZ TherapeuticsPhase 3
30